Cardlytics, Inc. — Director's Dealing 2026

Jan 16, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2026-01-12

Reporting Person: Evans David Thomas (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-12	Restricted Stock Units	$	A	1000000	Acquired		Common Stock (1000000)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2: 50% of the shares underlying the RSU award will vest on February 1, 2027, with the remaining 50% vesting in equal amounts quarterly over a one-year period through February 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates.